![[Bio USA] Korean biotechs bolster AstraZeneca partnership](https://images.weserv.nl/?url=wimg.heraldcorp.com%2Fnews%2Fcms%2F2026%2F06%2F23%2Fnews-p.v1.20260623.78369bb8ff2d45cc848eea83d0c0d815_T1.jpg&w=3840&q=75&output=webp&we)
KRKorean biotechnology firms have strengthened their partnerships with AstraZeneca through Project NOVA, an initiative organized by the Korea Health Industry Development Institute (KHIDI). During the BIO International Convention in San Diego, 13 Korean biotech companies participated in one-on-one sessions with AstraZeneca experts to showcase their technologies and receive evaluations. The goal is to facilitate open innovation and help these firms enter the global market. AstraZeneca emphasized the importance of such collaborations in advancing drug development for patients. KHIDI highlighted that open innovation is crucial for securing cutting-edge technology and positioning Korean biotech companies on the global stage. This effort is part of a broader government initiative called K-Biopharma Next Bridge, which aims to enhance open innovation in South Korea's pharmaceutical sector through partnerships with major international pharmaceutical companies.
Bias read (Center): The article focuses on business collaborations between Korean biotech firms and AstraZeneca, emphasizing open innovation and market expansion. There is no mention of political figures, policies, or contentious issues. The content remains neutral, focusing on industry developments and partnerships.
